The number and location of tumors developing in the body determines a diagnosis of stage 3 non-Hodgkin lymphoma. This diagnosis process is called staging and involves tests of one or more of the following: a bone marrow biopsy, CT scan, MRI, ultrasound, spinal tap, or PET scan. Stage 3 indicates tumors spread throughout the lymphatic system, and possibly invading other tissues and organs. It can also be classified as "indolent" in medical terms-meaning the disease is very responsive to treatment and those diagnosed with it can expect to survive many years-or aggressive, requiring intensive treatment. It should be noted that stage 3 non-Hodgkin lymphoma is almost always diagnosed as indolent.
Continue Learning about Non-Hodgkin's Lymphoma
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.